Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
109 hedge funds and large institutions have $237M invested in Enzo Biochem, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 35 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
26% more capital invested
Capital invested by funds: $188M → $237M (+$48.7M)
6% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 35
0% more funds holding
Funds holding: 109 → 109 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$22.4M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.7M |
| 3 |
CA
Corrado Advisors
Ramsey,
New Jersey
|
+$2.12M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.82M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
-$1.42M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$661K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$634K |
| 4 |
Morgan Stanley
New York
|
-$610K |
| 5 |
PA
Perceptive Advisors
New York
|
-$582K |
ENZ Hedge Fund Activity: Q1 2017 in Review
109 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2017, worth a combined $237M — up 26% from $188M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ENZ positions and 9 closed out — a net gain of 5 holders — while 37 added to existing stakes and 35 trimmed.
The largest buyer was BlackRock, adding an estimated $22.4M. The largest seller was Globeflex Capital, cutting an estimated $1.42M.
- 109 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $237M of Enzo Biochem, Inc. stock for Q1 2017, up 26% quarter-over-quarter.
- 14 funds opened new Enzo Biochem, Inc. positions in Q1 2017 and 9 closed out, a net change of +5 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2017 was BlackRock, an estimated $22.4M added.
- The largest Enzo Biochem, Inc. seller in Q1 2017 was Globeflex Capital, an estimated $1.42M sold.
Based on aggregated 13F filings for Q1 2017.